S100A13 and diabetes mellitus: A decreased protein level in PDAC+ DM compared to PDAC was also detected via Western blots, which indicates a lower influence of S100A13 on tumor angiogenesis in these PDAC patients, rendering S100A13 an interesting marker for patients with PDAC+ DM.